Skip Navigation and Go To Content
News from The University of Texas Health Science Center at Houston

Stories from The University of Texas Health Science Center at Houston (UTHealth Houston)

Navigation and Search

News Archive

38-year-old woman makes full recovery after ischemic stroke after participating in nationwide stroke study at UTHealth Houston

Andrea Arismendez enjoys spending time with her two sons, now that she has fully recovered from the stroke she suffered earlier this year. (Photo courtesy of Andrea Arismendez)

September 15, 2022

Having experienced a stroke less than three hours before being admitted to the hospital, Andrea Arsimendez qualified for the Multi-arm Optimization of Stroke Thrombolysis (MOST) clinical trial at UTHealth Houston, which is investigating which blood thinner – argatroban or epitifibatide – improves recovery among acute ischemic stroke patients treated with standard-of-care thrombolysis within three hours of symptom onset.

Study examines diversity trends in pediatric population

Researchers examined 367,863 pediatric faculty and found the URiM female representation increased from 4.4% in 2000 to 7.8% in 2020 in the pediatric field.

August 31, 2022

The rate of underrepresented in medicine (URiM) women in the pediatric field have significantly increased, but the rates have remained stagnant and decreased in Black men, according to researchers with UTHealth Houston.

Second patient in the world receives Moderna mRNA trial infusion at UTHealth Houston for glycogen storage disease

Rebecca Tarrence, an 18-year-old from Arizona, is the second person in the world to receive the Moderna mRNA infusion as part of the Ba1ance Trial for GSDIa at UTHealth Houston led by David Rodriguez-Buritica, MD. (Photo by UTHealth Houston)

August 30, 2022

Imagine having to drink a solution of cornstarch and water every four hours to survive, and that missing a dose, even by 15 minutes, could lead to seizures and death. This is the reality for Rebecca Tarrence, who has glycogen storage disease type 1a (GSDIa), a rare genetic disease caused by the presence of two genetic changes on the same gene affecting glucose production.

Page 27 of 40

Search UTHealth News

Use the form below to perform a new search.